Eagle Health Investments’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-81,121
Closed -$12.9M 23
2025
Q1
$12.9M Sell
81,121
-55,482
-41% -$10M 3.36% 13
2024
Q4
$25.3M Hold
136,603
6.21% 8
2024
Q3
$28.8M Hold
136,603
5.46% 11
2024
Q2
$18.3M Buy
136,603
+14,400
+12% +$2.73M 3.21% 15
2024
Q1
$26.2M Buy
122,203
+8,700
+8% +$1.71M 4.88% 9
2023
Q4
$23.1M Buy
113,503
+20,260
+22% +$3.28M 4.69% 11
2023
Q3
$18.5M Buy
93,243
+20,400
+28% +$5.14M 4.08% 12
2023
Q2
$23.6M Sell
72,843
-28,700
-28% -$8.2M 4.42% 11
2023
Q1
$23.8M Hold
101,543
4.63% 11
2022
Q4
$25.6M Buy
101,543
+990
+1% +$211K 5.9% 9
2022
Q3
$17.8M Buy
100,553
+6,400
+7% +$1.29M 4.09% 14
2022
Q2
$17.2M Buy
94,153
+17,900
+23% +$3.57M 4.01% 11
2022
Q1
$19.6M Hold
76,253
4.82% 10
2021
Q4
$17.5M Buy
76,253
+7,600
+11% +$1.86M 4.27% 11
2021
Q3
$16M Buy
68,653
+12,600
+22% +$2.63M 5.07% 11
2021
Q2
$10.8M Buy
56,053
+18,600
+50% +$3.69M 3.72% 13
2021
Q1
$7.75M Buy
+37,453
New +$7.96M 3.04% 15

Other funds holding INSP

Eagle Health Investments's INSP Position: Q2 2025 in Review

Eagle Health Investments sold out of Inspire Medical Systems (INSP) in Q2 2025, closing a stake of 81,121 shares — an estimated $12.9M sold.

Eagle Health Investments first reported a position in INSP in Q1 2021 and held it in 17 quarters. The position peaked at $28.8M in Q3 2024. 356 funds tracked by Wall St. Rank hold INSP as of Q2 2025.

  • Eagle Health Investments reported no remaining Inspire Medical Systems position as of Q2 2025 after selling out during the quarter.
  • Eagle Health Investments sold 81,121 Inspire Medical Systems shares in Q2 2025, an estimated $12.9M.
  • Eagle Health Investments first reported a position in Inspire Medical Systems in Q1 2021 and held it in 17 quarters.
  • Eagle Health Investments's Inspire Medical Systems position peaked at $28.8M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2025.

Based on Eagle Health Investments's 13F filing for Q2 2025, filed 12 Aug 2025.